Tolterodine
Drugs For Urinary Frequency and Incontinence
- Drug class
- Drugs For Urinary Frequency and Incontinence
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 26
Overview
Plain-language summary, compiled from the cited regulatory records
Tolterodine is a medication classified as a drug for urinary frequency and incontinence [1]. It is approved for the treatment of overactive bladder, specifically addressing symptoms such as urge urinary incontinence, urgency, and urinary frequency [1].
This medication helps manage the symptoms associated with an overactive bladder. It functions as an antimuscarinic agent [1]. Tolterodine is available in extended-release capsule formulations [1].
Tolterodine is marketed under various brand names. In the twelve months prior to the most recent data update, there were no adverse event reports submitted for this active ingredient [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 24 | May 1, 2026 |
| US United States | FDA | 2 | January 6, 2026 |
GBUnited Kingdom· MHRA
24 products
Uses
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
How to take
USUnited States· FDA
2 products
Uses
1. INDICATIONS AND USAGE Tolterodine tartrate extended-release capsules, USP are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES (14) ] . Tolterodine tartrate extended-release capsules, USP are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
(1)
How to take
Drug interactions
Known interactions involving Tolterodine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 540. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL200750357 · revised May 1, 2026
- [2]FDA DailyMed · 05b92da2-923b-3c… · revised January 6, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.